TKT and metastatic malignant neoplasm: When comparing the relative mutational load in primary vs metastatic cancers, kinases in the TK group had a borderline significantly greater mutational load in metastatic cancers (P = 0.05) and a higher CNA load compared to primary tumors (Fig. 4).